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Edited by Laszlo NagyAbstract The proto-oncogene protein DEK has been implicated
in the t(6;9) chromosomal translocation associated with a sub-
type of acute myelogenous leukemia (AML), which results in
the formation of a DEK-CAN fusion protein. Histone acetyla-
tion is an important post-translational modiﬁcation which is in-
volved in transcriptional regulation. In this study, we report
that the acidic domain containing protein DEK interacts with
histones and exerts a potent inhibitory eﬀect on both p300 and
PCAF-mediated histone acetyltransferase activity and transcrip-
tion. Using chromatin immunoprecipitation assays, we have dem-
onstrated that the recruitment of DEK to the appropriate
promoter induces the histone H3 and H4 hypoacetylation of
chromatin. Collectively, our data illustrate the important regula-
tory role played by protein DEK in transcriptional regulation,
and suggest that transcription-regulating acidic domain regions
may play a role in leukemogenesis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The DEK protein was initially identiﬁed in a fusion with the
CAN nucleoporin protein, in a speciﬁc acute myelogenous leu-
kemia (AML) subtype with a translocation (6;9) which results
in the formation of a dek-can fusion gene [1]. As a ubiquitous
nuclear protein, DEK possesses the major DNA binding do-
main (DBD) SAP box, and at least three highly acidic domains
[2]. The acidic domain harboring the N-terminal two-thirds of
the DEK protein has been shown to be fused to the C-terminal
two-thirds of CAN in the DEK-CAN fusion protein [3]. In
addition to DEK, another onco-protein, designated SET/
TAF-Ibeta, has also been demonstrated to form a fusion pro-
tein with CAN in cases of undiﬀerentiated leukemia [4]. SET/Abbreviations: HAT, histone acetyltransferase; INHAT, inhibitors of
acetyltransferases; DBD, DNA binding domain; PCR, polymerase
chain reaction
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doi:10.1016/j.febslet.2006.04.081TAF-Ibeta is a subunit of the recently puriﬁed and character-
ized inhibitors of acetyltransferases (INHAT) complex, which
targets histones and blocks their acetylation by p300/CBP and
PCAF [5]. The INHAT complex subunits, including SET/
TAF-Ibeta, are known to harbor highly acidic domains, and
these acidic domains are believed to be responsible for the his-
tone acetyltransferase (HAT) inhibitory activity [5].
The transcriptional coactivators p300/CBP and PCAF exhi-
bit HAT activity, and play vital roles in transcription [6]. His-
tone acetylation’s marked importance in the processes of
chromatin modiﬁcation and transcription suggests that this
process should be regulated fairly tightly. Recent reports have
suggested that the DEK proto-oncogene protein performs vital
functions in chromatin remodeling, via the alteration of the
topology of chromatin [7]. Also, the latency-associated nuclear
antigen (LANA) has been shown to interact directly with DEK
and the methyl CpG-binding protein, MeCP2, in cases of Ka-
posi’s sarcoma [8]. Hollenbach et al. proposed that DEK is one
component of a multiprotein transcriptional repressor complex
which includes hDaxx and HDAC2 [9]. The similarity of the
SET-CAN and DEK-CAN transfusion proteins, with regard
to the presence of highly acidic domains compelled us to ascer-
tain whether the DEK protein exhibits any SET/TAF-Ibeta
like HAT regulatory eﬀects via its acidic domains.
In this study, we characterized p300- and PCAF-mediated
HAT inhibitory activities of protein DEK through its acidic
domain containing regions. We have demonstrated that
DEK is able to bind to histones in the presence of acidic do-
main and when targeted to a promoter, DEK was shown to re-
duce the levels of histone H3 and H4 acetylation in vivo.
Collectively, our data indicate that the human DEK protein
plays a novel regulatory role in the process of histone acetyla-
tion and transcription.2. Materials and methods
2.1. Plasmids and proteins
For bacterial and eukaryotic expression constructs of pp32, SET/
TAF-Ibeta, DEK and their derivates, the appropriate polymerase
chain reaction (PCR)-ampliﬁed fragments were cloned into pGEX-
4T1, pGEX-2TK, CMX-PL1, CMX-Gal4 vectors [5]. Recombinant
GST proteins were expressed in BL 21 (DE3) E. coli cells (Novagene)
and puriﬁed using glutathione beads (Amersham Biosciences). Puriﬁ-
cation of baculovirus-expressed Flag-p300 and Flag-PCAF was carried
out as described [10]. Minimal HAT domain proteins of p300 and
PCAF were obtained commercially (Upstate Biotechnology).blished by Elsevier B.V. All rights reserved.
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Histones (Chemicon International) and puriﬁed nucleosome ace-
tyltransferase assays were performed as described previously [5,10].
For HAT inhibition assay, approximately 7, 15 pmol of GST-
DEK or 15 pmol of GST-pp32 was preincubated with 1 pmol of
p300 or PCAF shortly and 1 lg (50 pmol) of histones, and 14[C]-ace-
tyl CoA (50 lCi/ll, 1000 pmol/ll, Amersham) were added for
20 min at 30 C.
2.3. In vitro immunoprecipitation and interaction assays
For histone interaction assays, GST-DEK and derivatives were incu-
bated with or without histones and immunoprecipitated with anti-his-
tone antibodies (Chemicon International) and protein A agarose beads
(Amersham). Bound proteins were analyzed in immunoblots using
anti-DEK (BD Biosciences) and anti-GST antibodies (Santa Cruz Bio-
technology).
2.4. Transfection assay
K562 cells were seeded in 48 well dishes and transfected by lipofect-
amine 2000 (Invitrogen) with internal control MH100TK-Luc
(100 ng), CMX-Gal4CBP (100 ng) in the absence or presence of
CMXPL1 derivatives of pp32 (50, 100 ng), SET/TAF-Ibeta (50,
100 ng), DEK (50, 100, 200 ng). HeLa cells were transfected with
MH100SV-Luc (100 ng), CMX-Gal4N (50 ng), Gal4-SET/TAF-Ibeta
(100, 200 ng), and Gal4-DEK (100, 200 ng) where indicated. Cells were
harvested and assayed for luciferase activity using the luciferase assay
system (Promega) and normalized by the GFP level after the pEGFP-
C1 (20 ng) co-transfection. The results shown are representative of at
least three independent experiments.Fig. 1. DEK exhibits p300- and PCAF-mediated HAT inhibitory activity. (
DEK (p300 and PCAF, lanes 4, 5) or GST (p300 and PCAF, lane 2). In lane
p300 and PCAF were incubated with puriﬁed GST-pp32. (B) PCAF and p300
nucleosomes. Nucleosome formation was shown in agarose gel (right panel). (
PCAF (352–832) were incubated without (lanes 1, 3, 5) or with (lanes 2, 4,2.5. Chromatin immunoprecipitation (ChIP)
ChIP was carried out as described in the protocols from Upstate
Biotechnology. Brieﬂy, 2 · 105 of HeLa cells were transfected with
1.5 lg of DNA and harvested 48 h later. Cells were cross-linked with
1% formaldehyde and sonicated for immunoprecipitation with 5 lg
of anti-acetylated histone H3 and H4 antibodies (Upstate Biotechnol-
ogy), and anti-Gal4 DBD antibodies (Santa Cruz Biotechnology).
After the immunoprecipitates were eluted and cross-link reversed,
DNA fragments were puriﬁed and ampliﬁed by PCR for quantitation.
Primers utilized for Gal4-SV40 promoter analysis are 5 0-
tgtactttatggtactgtaactg-30 and 5 0-ctttatgtttttggcgtcttcca-3 0. Each exper-
iment was repeated at least three times with similar results. Results
shown are representative of the data. For lysine speciﬁcity of inhibition
analysis, anti-acetyl histone H4 (Lys 8, 12, 16) and anti-acetyl histone
H3 (Lys 14) antibodies (Upstate Biotechnology) were used.3. Results
3.1. Identiﬁcation of DEK as a HAT inhibitory protein
One of the distinct characteristics of the 375-amino acid hu-
man DEK protein is its possession of at least 3 highly acidic
amino acid regions (amino acids 30–49, 228–254, 300–327).
In order to investigate whether the DEK protein exhibits
HAT inhibitory properties, we conducted a series of HAT as-
says via the addition of GST-DEK fusion proteins to baculovi-
rally expressed p300 and PCAF with core histones and 14[C]A) Histones were incubated with p300 and PCAF, with puriﬁed GST-
1, the p300 and PCAF were incubated solely with histones. In lane 3,
were incubated without or with GST-DEK, prior to the addition of the
C) Minimal HAT domains of p300 (1195–1707), CBP (1430–1680), and
6) DEK, prior to histone addition.
Fig. 2. Mapping of the HAT inhibitory domain of DEK. (A) Recombinant GST-DEK and deletion proteins were assayed in PCAF-mediated
acetylation assays of total histones. The HAT inhibitory activity is also designated as ++++ (high activity) to + (little activity,  20% of the wild
type). The highly acidic domains are marked with three dark boxes. (B) Inhibitory activity of histone acetylation was shown in phosphorimage.
Puriﬁed GST-DEK and deletion proteins were shown in SDS–PAGE gel.
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of GST-DEK, p300- and PCAF-mediated acetylations were
dose-dependently inhibited (Fig. 1A lanes 4, 5 p300, and 4, 5
PCAF). Relatively small inhibitory eﬀect in the presence of
low concentration of PCAF compare to that of p300 might
indicate diﬀerent HAT inhibitory mechanism by DEK between
two diﬀerent enzymes. As has been previously reported, one of
the INHAT subunits, GST-pp32 also exerted an inhibitory ef-
fect on p300- and PCAF-mediated acetylation (Fig. 1A, lanes 3
p300, PCAF). We also attempted to characterize the eﬀects of
DEK on nucleosome acetylation. As had been expected, GST-
DEK inhibited PCAF-mediated acetylation of nucleosomes, in
a fashion quite similar to that observed with puriﬁed histones
(Fig. 1B). GST-DEK was also shown to block histone acetyla-
tion by the puriﬁed p300, CBP, and PCAF minimal HAT do-
mains (Fig. 1C).
3.2. Mapping of the HAT inhibitory domain of DEK
A series of C-terminal deletion mutant GST-DEK proteins
revealed that DEK: C290 which lost regions containing acidic
domain III showed slightly decreased HAT inhibitory activity
compare to that of the wild type DEK (Fig. 2B phosphorim-
ager DEK: C290). When regions containing both acidic do-
main II and III were lost as in DEK: C200, HAT inhibitory
activity was further decreased (Fig. 2B phosphorimager
DEK: C200). The HAT inhibitory activity manifested by
DEK was the most profound in wild type which contains allthree acidic domains (Fig. 2A and B DEK). Results of the as-
says with DEK: N60 revealed that the ﬁrst acidic domain I
containing region also contributed to HAT inhibitory activity,
although weakly. To our surprise, even DEK: 60–200, which
contained none of the three acidic domains, also evidenced
HAT inhibitory activity (Fig. 2A and B DEK: 60–200). This
is likely attributable to the slightly higher composition of
acidic residues between amino acids 60–90 and 140–180 in this
deletion mutant. However, it is possible that these regions
could be involved regardless of acidic amino acid composition.
These observations suggest that acidic domain I containing re-
gion dose not seem to contribute to the overall HAT inhibitory
activity of DEK as much as the other two acidic domain con-
taining regions.
3.3. DEK binds to histones in the presence of acidic domain
In order to address the issue as to whether the acidic do-
mains of DEK are responsible for histone binding, we con-
ducted immunoprecipitation assays with both histones and
DEK. As had been expected, our in vitro assay utilizing
GST full-length DEK and anti-histone antibody indicated an
interaction between DEK and histones (Fig. 3 GST-DEK).
In contrast, there were no non-speciﬁc bindings between
GST-DEKs and anti-histones antibodies in the absence of his-
tones (Fig. 3 lanes 3, 6, 9, 12, and 15). Our binding assays indi-
cated that the GST-DEK deletion mutants which harboring at
least one acidic domain exhibited histone-binding aﬃnity
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DEK: 60–200 evidenced weak HAT inhibitory activity, it
was not observed to bind histones (Fig. 3 DEK: 60–200). These
results indicated that DEK binds to histones via interaction
with highly acidic domains.
3.4. Transcriptional properties of DEK
To elucidate whether DEK repress the HAT mediated trans-
activation, we ﬁrst attempted to determine whether DEK
would aﬀect Gal4-CBP mediated transcriptional activation in
K562 leukemia cell line. We and others have shown that a
Gal4-CBP activates transcription in a HAT dependent manner
[5,11]. Co-transfection of CMX-SET/TAF-Ibeta and CMX-
pp32 inhibited Gal4-CBP mediated transactivation through
their HAT inhibitory activity as previously reported (Fig. 4A
lanes 3–4) [5]. As had been expected from its observed
in vitro HAT inhibitory activity, transfection with CMX-
DEK inhibited HAT-mediated transactivation in a dose-
dependent manner (Fig. 4A DEK lanes 5–7). We next asked
whether direct recruitment of DEK to the promoter could
mediate transcritptional repression. The Gal4-DEK fusion
protein repressed the basal transcription of the reporter gene
as similar to the Gal4-SET/TAF-Ibeta in HeLa cells (Fig. 4B
lanes 3–4 and 5–6).Fig. 3. DEK binds to histones via acidic domain containing regions GST-DE
5, 8, 11, and 14) or without (lanes 3, 6, 9, 12 and 15) histones, and immu
detected via immunoblot analysis using anti-DEK (lanes 1–3) or anti-GST (3.5. Targeting of DEK to promoter causes chromatin
hypoacetylation
In order to characterize the mechanism underlying DEK-
mediated transcriptional repression, we conducted ChIP as-
says with anti-acetylated histone H3 and H4 antibodies,
and compared the levels of histone acetylation. With a con-
stant level of input DNA from cells transfected with either
Gal4 DBD or Gal4 DBD-DEK (Fig. 5A lanes 2 and 4),
comparable amounts of Gal4 DBD and Gal4 DBD-DEK
were recruited to the promoter (Fig. 5A lanes 5 and 8).
Mouse IgG was used for negative control (Fig. 5A lanes 1
and 3). In a ﬁnding consistent with the previous results in
this study, we noted a fair amount of decrease in the level
of histone H3 and substantial decrease in the level of H4
acetylation of promoters, in the presence of Gal4 DBD-
DEK (Fig. 5A compare lanes 6 and 9, and lanes 7 and
10). In an attempt to determine whether or not DEK exhib-
its any lysine residue speciﬁcity in its inhibitory eﬀects on
acetylation, we further conducted a series of ChIP analyses
using antibodies speciﬁc for individually acetylated histone
H3 and H4 lysine residues. The data indicated that all of
the tested lysine residues (H3 K14, H4 K8, H4 K12, and
H4 K16) showed signiﬁcant decrease in acetylation level on
the promoter when Gal4 DBD-DEK is present (Fig. 5BK and deletion proteins were separately incubated either with (lanes 2,
noprecipitated with anti-histone antibodies. The bound proteins were
lanes 4–15). Lanes 1, 4, 7, 10, and 13 represent 15% of the input.
Fig. 4. DEK represses HAT-dependent and basal transactivation. K562 (A) and HeLa (B) cells were transfected with the pMH100-TK-Luc,
pMH100-SV-Luc, CMX-Gal4-CBP CMX-Gal4N, CMX-DEK, and CMX-Gal4-DEK, as indicated. Immunoblot controls are provided for the
expression of pp32, SET/TAF-Ibeta, and DEK proteins in co-transfected cells (right panel).
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8, lysine 16 of histone H4 and lysine 14 of H3 are linked to
transcriptional activation and that of H4 lysine 12 to histone
deposition [12]. On the basis of these results, we provide evi-
dence that DEK plays an important role in transcriptional
repression, via the in vivo promotion of targeted histone
hypoacetylation.4. Discussion
Despite the number of reports which have associated DEK
with certain diseases, including cancer, little remains conﬁ-
dently known regarding its functions. In this study, we have
provided evidence that the DEK nuclear protein exhibits
inhibitory activity towards p300/CBP- and PCAF-mediated
histone acetylation. We have also presented the evidence that
the DEK protein binds to histones through acidic domains.
We also showed that each of the tested acidic domains exhib-
ited some degree of HAT inhibitory activity, and synergisti-
cally contributed to the total activity of the full-length DEK.When transiently overexpressed, DEK inhibits Gal4-CBP-
mediated transactivation, implicating DEK in the regulation
of HAT-mediated transcription. CBP has been known to asso-
ciates with RNA Pol II complex which suggests the lack of
strong inhibitory activity might be due to the unidentiﬁed
mechanism of DEK in that process [13]. Moreover, the associ-
ation of DEK with the repressive status of chromatin was bol-
stered by the observation that chromatin-targeted DEK
promotes histone hypoacetylation.
In summary, our study provides evidence that human DEK
mediates transcriptional repression via its HAT regulatory ef-
fects. Our results provide another piece of critical information
regarding the importance of highly acidic domain containing
proteins in both transcriptional regulation and chromatin
modiﬁcation. Further investigations into the roles played by
the DEK and DEK-CAN proteins in transcriptional regula-
tion through interaction with corepressors or coactivators
may provide more deﬁnite information regarding the role of
these acidic domain containing proteins in the mechanisms
underlying the pathogenesis of human diseases, including leu-
kemia.
Fig. 5. Targeting of DEK to chromatin causes a decrease in histone H3, H4 acetylation.The HeLa cells were transfected with the gal4-SV40-luc
reporter gene along with either the Gal4-DBD or Gal4-DBD DEK. Following transfection, ChIP assays, employing control IgG, anti-Gal4, anti-
acetyl histone H3, anti-acetyl histone H4 antibodies (A), or anti-acetyl histone H4 (Lys 8, 12, 16) and anti-acetyl histone H3 (Lys 14) antibodies (B)
were conducted. The immunoprecipitated DNA fragments were ampliﬁed by PCR from the promoter region of the integrated gal4-SV40-luc reporter
gene. Expression of Gal4-DBD and Gal4-DEK proteins were immunoblotted with anti-Gal4 DBD antibodies (A, right panel).
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